Protocol for a double-blind placebo-controlled randomised controlled trial assessing the impact of oral semaglutide in amyloid positivity (ISAP) in community dwelling UK adults.

Ivan KoychevAmanda I AdlerPaul EdisonBrian TomJoanne E MiltonJoe ButchartAdam HampshireCharles MarshallElizabeth CoulthardHenrik ZetterbergPeter HellyerFrancesca CormackBenjamin R UnderwoodCatherine J MummeryRury R Holman

Published in: BMJ open (2024)

ISRCTN71283871.

Keyphrases

community dwelling
study protocol
placebo controlled
randomized controlled trial
double blind
clinical trial
phase iii
phase ii
cross sectional
open label
phase ii study
squamous cell carcinoma